EUVIMEDEUVIMED entdecken
Crossref

Evaluating Causal Effects on Time‐to‐Event Outcomes in an RCT in Oncology With Treatment Discontinuation

Veronica Ballerini iD, Björn Bornkamp iD, Fabrizia Mealli iD, Craig Wang iD, Yufen Zhang, Alessandra Mattei iD

Biometrical Journal · 2025

DOI: 10.1002/bimj.70092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biometrical Journal, 2025. Verfasst von Veronica Ballerini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Neoplasms, Biometry, Medical Oncology. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Ministero dell'Università e della Ricerca, European Union - Next GenerationEU, UNIFI Young Independent Researchers Call.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In clinical trials, patients may discontinue treatments prematurely, breaking the initial randomization. In our motivating study, a randomized controlled trial in oncology, patients assigned the investigational treatment may discontinue it due to adverse events. The ICH E9(R1) Addendum provides guidelines for handling such “intercurrent events.” The right strategy to adopt depends on the questions of interest. We propose adopting a principal stratum strategy and decomposing the overall intention‐to‐treat effect into principal causal effects for groups of patients defined by their potential discontinuation behaviour. We first show how to implement a principal stratum strategy to assess causal effects on a survival outcome in the presence of continuous‐time treatment discontinuation, its advantages, and the conclusions that can be drawn. Our strategy allows us to properly handle the time‐to‐event intermediate variable, which is not defined for patients who would not discontinue, and to account for the fact that the discontinuation time and the primary endpoint are subject to censoring. We employ a flexible model‐based Bayesian approach to tackle these complexities, providing easily interpretable results. We apply this Bayesian principal stratification framework to analyze synthetic data of the motivating oncology trial. Supported by a simulation study, we shed light on the role of covariates in this framework. Beyond making structural and parametric assumptions more credible, they lead to more precise inference. Also, they can be used to characterize patients' discontinuation behavior, which could help inform clinical practice and future protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicNeoplasmsBiometryMedical OncologyHumansBayes TheoremTreatment OutcomeTime FactorsCausality

Stichwörter der Autor:innen

Bayesian analysiscausal inferencecensoringpotential outcomesprincipal stratificationsurvival analysis

Autor:innen und Institutionen

  • Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Advanced Quantitative Sciences, Novartis Pharma AG, Basel, Switzerland.
  • Department of Economics, European University Institute, Fiesole, Italy | Florence Center for Data Science, University of Florence, Florence, Italy.
  • Advanced Quantitative Sciences, Novartis Pharmaceuticals Corporation, New Jersey, USA.
  • Department of Statistics, Computer Science, Applications "G. Parenti", Florence Center for Data Science, University of Florence, Florence, Italy.

ORCID-Profile: Veronica Ballerini, Björn Bornkamp, Fabrizia Mealli, Craig Wang, Alessandra Mattei

Förderung

  • Ministero dell'Università e della Ricerca
  • European Union - Next GenerationEU, UNIFI Young Independent Researchers Call

Zitieren

APA

Ballerini, V., Bornkamp, B., Mealli, F., Wang, C., Zhang, Y., & Mattei, A. (2025). Evaluating Causal Effects on Time‐to‐Event Outcomes in an RCT in Oncology With Treatment Discontinuation. Biometrical Journal. https://doi.org/10.1002/bimj.70092

Vancouver

Ballerini V, Bornkamp B, Mealli F, Wang C, Zhang Y, Mattei A. Evaluating Causal Effects on Time‐to‐Event Outcomes in an RCT in Oncology With Treatment Discontinuation. Biometrical Journal. 2025. doi:10.1002/bimj.70092

BibTeX
@article{Ballerini2025,
  author = {Ballerini, Veronica and Bornkamp, Björn and Mealli, Fabrizia and Wang, Craig and Zhang, Yufen and Mattei, Alessandra},
  title = {Evaluating Causal Effects on Time‐to‐Event Outcomes in an RCT in Oncology With Treatment Discontinuation},
  journal = {Biometrical Journal},
  year = {2025},
  doi = {10.1002/bimj.70092}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche